Selected research
Market Analysis & Forecast
Global Oral Testosterone Market Analysis and Forecast 2026-2032
Market perspective
The global Oral Testosterone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Testosterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oral Testosterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Oral Testosterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oral Testosterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Oral Testosterone include Zhejiang Medicine, Tianjin Lisheng Pharmaceutical, Novo Nordisk, Mylan, Bayer, Sunpharma, Power Health, Organon and Marius Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Testosterone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oral Testosterone, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Testosterone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Testosterone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Testosterone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Testosterone sales, projected growth trends, production technology, application and end-user industry.
Oral Testosterone Segment by Company
Zhejiang Medicine
Tianjin Lisheng Pharmaceutical
Novo Nordisk
Mylan
Bayer
Sunpharma
Power Health
Organon
Marius Pharmaceuticals
Endo Pharmaceuticals
Clarus Therapeutics
Ardana
Antares Pharma
Oral Testosterone Segment by Type
Capsules
Tablets
Oral Testosterone Segment by Application
Medical
Research
Oral Testosterone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Testosterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Testosterone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Testosterone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oral Testosterone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oral Testosterone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Testosterone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Medical
- Research
Companies covered
- Zhejiang Medicine
- Tianjin Lisheng Pharmaceutical
- Novo Nordisk
- Mylan
- Bayer
- Sunpharma
- Power Health
- Organon
- Marius Pharmaceuticals
- Endo Pharmaceuticals
- Clarus Therapeutics
- Ardana
- Antares Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oral Testosterone Market by Type
- 1.2.1 Global Oral Testosterone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Capsules
- 1.2.3 Tablets
- 1.3 Oral Testosterone Market by Application
- 1.3.1 Global Oral Testosterone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Research
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oral Testosterone Market Dynamics
- 2.1 Oral Testosterone Industry Trends
- 2.2 Oral Testosterone Industry Drivers
- 2.3 Oral Testosterone Industry Opportunities and Challenges
- 2.4 Oral Testosterone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Oral Testosterone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Oral Testosterone Revenue by Region
- 3.2.1 Global Oral Testosterone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oral Testosterone Revenue by Region (2021-2026)
- 3.2.3 Global Oral Testosterone Revenue by Region (2027-2032)
- 3.2.4 Global Oral Testosterone Revenue Market Share by Region (2021-2032)
- 3.3 Global Oral Testosterone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Oral Testosterone Sales by Region
- 3.4.1 Global Oral Testosterone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Oral Testosterone Sales by Region (2021-2026)
- 3.4.3 Global Oral Testosterone Sales by Region (2027-2032)
- 3.4.4 Global Oral Testosterone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oral Testosterone Revenue by Manufacturers
- 4.1.1 Global Oral Testosterone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Oral Testosterone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Oral Testosterone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oral Testosterone Sales by Manufacturers
- 4.2.1 Global Oral Testosterone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Oral Testosterone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Oral Testosterone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Oral Testosterone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Oral Testosterone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Oral Testosterone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oral Testosterone Manufacturers, Product Type & Application
- 4.7 Global Oral Testosterone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oral Testosterone Market CR5 and HHI
- 4.8.2 2025 Oral Testosterone Tier 1, Tier 2, and Tier 3
5 Oral Testosterone Market by Type
- 5.1 Global Oral Testosterone Revenue by Type
- 5.1.1 Global Oral Testosterone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Oral Testosterone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Oral Testosterone Revenue Market Share by Type (2021-2032)
- 5.2 Global Oral Testosterone Sales by Type
- 5.2.1 Global Oral Testosterone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Testosterone Sales by Type (2021-2032) & (kg)
- 5.2.3 Global Oral Testosterone Sales Market Share by Type (2021-2032)
- 5.3 Global Oral Testosterone Price by Type
6 Oral Testosterone Market by Application
- 6.1 Global Oral Testosterone Revenue by Application
- 6.1.1 Global Oral Testosterone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Oral Testosterone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Oral Testosterone Revenue Market Share by Application (2021-2032)
- 6.2 Global Oral Testosterone Sales by Application
- 6.2.1 Global Oral Testosterone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Oral Testosterone Sales by Application (2021-2032) & (kg)
- 6.2.3 Global Oral Testosterone Sales Market Share by Application (2021-2032)
- 6.3 Global Oral Testosterone Price by Application
7 Company Profiles
- 7.1 Zhejiang Medicine
- 7.1.1 Zhejiang Medicine Company Information
- 7.1.2 Zhejiang Medicine Business Overview
- 7.1.3 Zhejiang Medicine Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zhejiang Medicine Oral Testosterone Product Portfolio
- 7.1.5 Zhejiang Medicine Recent Developments
- 7.2 Tianjin Lisheng Pharmaceutical
- 7.2.1 Tianjin Lisheng Pharmaceutical Company Information
- 7.2.2 Tianjin Lisheng Pharmaceutical Business Overview
- 7.2.3 Tianjin Lisheng Pharmaceutical Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Tianjin Lisheng Pharmaceutical Oral Testosterone Product Portfolio
- 7.2.5 Tianjin Lisheng Pharmaceutical Recent Developments
- 7.3 Novo Nordisk
- 7.3.1 Novo Nordisk Company Information
- 7.3.2 Novo Nordisk Business Overview
- 7.3.3 Novo Nordisk Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novo Nordisk Oral Testosterone Product Portfolio
- 7.3.5 Novo Nordisk Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Company Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mylan Oral Testosterone Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 Bayer
- 7.5.1 Bayer Company Information
- 7.5.2 Bayer Business Overview
- 7.5.3 Bayer Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Bayer Oral Testosterone Product Portfolio
- 7.5.5 Bayer Recent Developments
- 7.6 Sunpharma
- 7.6.1 Sunpharma Company Information
- 7.6.2 Sunpharma Business Overview
- 7.6.3 Sunpharma Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sunpharma Oral Testosterone Product Portfolio
- 7.6.5 Sunpharma Recent Developments
- 7.7 Power Health
- 7.7.1 Power Health Company Information
- 7.7.2 Power Health Business Overview
- 7.7.3 Power Health Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Power Health Oral Testosterone Product Portfolio
- 7.7.5 Power Health Recent Developments
- 7.8 Organon
- 7.8.1 Organon Company Information
- 7.8.2 Organon Business Overview
- 7.8.3 Organon Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Organon Oral Testosterone Product Portfolio
- 7.8.5 Organon Recent Developments
- 7.9 Marius Pharmaceuticals
- 7.9.1 Marius Pharmaceuticals Company Information
- 7.9.2 Marius Pharmaceuticals Business Overview
- 7.9.3 Marius Pharmaceuticals Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Marius Pharmaceuticals Oral Testosterone Product Portfolio
- 7.9.5 Marius Pharmaceuticals Recent Developments
- 7.10 Endo Pharmaceuticals
- 7.10.1 Endo Pharmaceuticals Company Information
- 7.10.2 Endo Pharmaceuticals Business Overview
- 7.10.3 Endo Pharmaceuticals Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Endo Pharmaceuticals Oral Testosterone Product Portfolio
- 7.10.5 Endo Pharmaceuticals Recent Developments
- 7.11 Clarus Therapeutics
- 7.11.1 Clarus Therapeutics Company Information
- 7.11.2 Clarus Therapeutics Business Overview
- 7.11.3 Clarus Therapeutics Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Clarus Therapeutics Oral Testosterone Product Portfolio
- 7.11.5 Clarus Therapeutics Recent Developments
- 7.12 Ardana
- 7.12.1 Ardana Company Information
- 7.12.2 Ardana Business Overview
- 7.12.3 Ardana Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Ardana Oral Testosterone Product Portfolio
- 7.12.5 Ardana Recent Developments
- 7.13 Antares Pharma
- 7.13.1 Antares Pharma Company Information
- 7.13.2 Antares Pharma Business Overview
- 7.13.3 Antares Pharma Oral Testosterone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Antares Pharma Oral Testosterone Product Portfolio
- 7.13.5 Antares Pharma Recent Developments
8 North America
- 8.1 North America Oral Testosterone Market Size by Type
- 8.1.1 North America Oral Testosterone Revenue by Type (2021-2032)
- 8.1.2 North America Oral Testosterone Sales by Type (2021-2032)
- 8.1.3 North America Oral Testosterone Price by Type (2021-2032)
- 8.2 North America Oral Testosterone Market Size by Application
- 8.2.1 North America Oral Testosterone Revenue by Application (2021-2032)
- 8.2.2 North America Oral Testosterone Sales by Application (2021-2032)
- 8.2.3 North America Oral Testosterone Price by Application (2021-2032)
- 8.3 North America Oral Testosterone Market Size by Country
- 8.3.1 North America Oral Testosterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Oral Testosterone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Oral Testosterone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Oral Testosterone Market Size by Type
- 9.1.1 Europe Oral Testosterone Revenue by Type (2021-2032)
- 9.1.2 Europe Oral Testosterone Sales by Type (2021-2032)
- 9.1.3 Europe Oral Testosterone Price by Type (2021-2032)
- 9.2 Europe Oral Testosterone Market Size by Application
- 9.2.1 Europe Oral Testosterone Revenue by Application (2021-2032)
- 9.2.2 Europe Oral Testosterone Sales by Application (2021-2032)
- 9.2.3 Europe Oral Testosterone Price by Application (2021-2032)
- 9.3 Europe Oral Testosterone Market Size by Country
- 9.3.1 Europe Oral Testosterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Oral Testosterone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Oral Testosterone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Oral Testosterone Market Size by Type
- 10.1.1 China Oral Testosterone Revenue by Type (2021-2032)
- 10.1.2 China Oral Testosterone Sales by Type (2021-2032)
- 10.1.3 China Oral Testosterone Price by Type (2021-2032)
- 10.2 China Oral Testosterone Market Size by Application
- 10.2.1 China Oral Testosterone Revenue by Application (2021-2032)
- 10.2.2 China Oral Testosterone Sales by Application (2021-2032)
- 10.2.3 China Oral Testosterone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oral Testosterone Market Size by Type
- 11.1.1 Asia Oral Testosterone Revenue by Type (2021-2032)
- 11.1.2 Asia Oral Testosterone Sales by Type (2021-2032)
- 11.1.3 Asia Oral Testosterone Price by Type (2021-2032)
- 11.2 Asia Oral Testosterone Market Size by Application
- 11.2.1 Asia Oral Testosterone Revenue by Application (2021-2032)
- 11.2.2 Asia Oral Testosterone Sales by Application (2021-2032)
- 11.2.3 Asia Oral Testosterone Price by Application (2021-2032)
- 11.3 Asia Oral Testosterone Market Size by Country
- 11.3.1 Asia Oral Testosterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Oral Testosterone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Oral Testosterone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oral Testosterone Market Size by Type
- 12.1.1 SAMEA Oral Testosterone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Oral Testosterone Sales by Type (2021-2032)
- 12.1.3 SAMEA Oral Testosterone Price by Type (2021-2032)
- 12.2 SAMEA Oral Testosterone Market Size by Application
- 12.2.1 SAMEA Oral Testosterone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Oral Testosterone Sales by Application (2021-2032)
- 12.2.3 SAMEA Oral Testosterone Price by Application (2021-2032)
- 12.3 SAMEA Oral Testosterone Market Size by Country
- 12.3.1 SAMEA Oral Testosterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Oral Testosterone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Oral Testosterone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Oral Testosterone Value Chain Analysis
- 13.1.1 Oral Testosterone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oral Testosterone Production Mode & Process
- 13.2 Oral Testosterone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oral Testosterone Distributors
- 13.2.3 Oral Testosterone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst